Talking to Your Patients
About Menopause

Tell a colleague
Your patients will have many questions about menopause and decisions to make about treatments. And they will look to their healthcare professional for guidance.

As you know, estrogen therapy (ET) can be an effective treatment for moderate to severe menopause symptoms and the prevention of postmenopausal osteoporosis.1 There are various estrogen therapy options available, but patients often prefer a patch. Some of the patches are very small, convenient and effective. But women may be concerned about the negative findings related to estrogen therapy from the Women’s Health Initiative (WHI) study. You can discuss with your patients that, while there are risks associated with Vivelle-Dot®, you will review the symptoms and risk/benefit profile with them before making any therapy decisions.

Read more about the risks and benefits of estrogen therapy.



The information contained within this Web site is appropriate for U.S. healthcare professionals only.

*IMS Health® National Prescription Audit Plus, April 2008

Copyright © 2008 Novogyne Pharmaceuticals. All rights reserved.

Healthcare Professional Home  About Vivelle-Dot  Patient Profiles  Talking to Your Patients  Library
Prescribing Information  Vivelle-Dot Home Page  Contact Us
About Novogyne  Glossary  Site Map  Privacy Policy
Terms of Use